A recent article by the International Institute for Sustainable Development (IISD) explores how the experience gained within the framework of the Cartagena Protocol on Biosafety to the Convention on Biological Diversity (CBD) can help regulate synthetic biology, gene drives and other emerging technologies.

Elsa Tsioumani, the author of the piece, presents an overview of the use of biotechnology over the years and how biosafety discussions have evolved since the 1980s. According to Tsioumani, these historical perspectives provide valuable lessons on how to assess novel technologies, as the debate over potential benefits and risks of modern biotechnology reinvents itself and research progresses.

Read the full article on the IISD's website.